Skip to main content
FTRE
NASDAQ Life Sciences

Fortrea Swings to Q3 Profit, Raises Full-Year Guidance Midpoints

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$25.8
Mkt Cap
$2.461B
52W Low
$8.55
52W High
$26.16
52W Position info
202% above low
Off High info
1.4% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $8.55 on elevated volume (2.3× avg).

Summary

Fortrea posted Q3 revenue of $691.5 million, down from $701.3 million a year ago, but flipped to a $0.6 million GAAP profit from a $15.9 million loss. Adjusted EBITDA rose to $58.0 million from $50.7 million and adjusted diluted EPS doubled to $0.28 from $0.12. Book-to-bill came in at 1.12x for the quarter and the trailing 12 months, and the company generated $52.5 million of free cash flow. The company cut backlog by $558 million to $7,316 million to reflect estimated scope and inactive trials, saying the adjustment has no impact on historical results or 2026 guidance. It raised the midpoints of full-year revenue ($2,665-$2,690 million) and adjusted EBITDA ($210-$218 million) guidance while narrowing both ranges. The stock is trading near its 52-week high of $26.16 ahead of the 8:00 am ET call, where management will face questions on the backlog write-down and whether bookings convert to revenue growth.

At the time of this announcement, FTRE was trading at $25.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $8.55 to $26.16. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Oct 29, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.14
Real-time Price: $19.79 info
Change: -$3.35 (-14%) info
Market Cap: $1.91B info
FTRE
Oct 29, 2026, 6:38 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $19.79 info
Change: -$5.98 (-23%) info
Market Cap: $1.91B info
FTRE
Sep 10, 2026, 8:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $19.79 info
Change: +$3.00 (+18%) info
Market Cap: $1.91B info
FTRE
Sep 10, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $19.79 info
Change: +$3.00 (+18%) info
Market Cap: $1.91B info
FTRE
Sep 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $17.72
Real-time Price: $19.79 info
Change: +$2.07 (+12%) info
Market Cap: $1.91B info